We investigate the fate of de novo mutations that occur during the in-host replication of a pathogenic virus, predicting the probability that such mutations are passed on during disease transmission to a new host. Using influenza A virus as a model organism, we develop a life-history model of the within-host dynamics of the infection, using a multitype branching process with a coupled deterministic model to capture the population of available target cells. We quantify the fate of neutral mutations and mutations affecting five life-history traits: clearance, attachment, budding, cell death, and eclipse phase timing. Despite the severity of disease transmission bottlenecks, our results suggest that in a single transmission event, several mutations that appeared de novo in the donor are likely to be transmitted to the recipient. Even in the absence of a selective advantage for these mutations, the sustained growth phase inherent in each disease transmission cycle generates genetic diversity that is not eliminated during the transmission bottleneck.
INTRODUCTION
Many pathogens experience population dynamics characterized by periods of rapid expansion, while 2 a host is colonized, interleaved with extreme bottlenecks during transmission to new hosts. The 3 effect of these transmission cycles on pathogen evolution has been well-studied, with particular focus 4 on long-standing predictions regarding the evolution of virulence ( In the experimental evolution of microbial populations, the impact of population bottlenecks has 10 also been studied in some depth, both theoretically (Bergstrom et clearly reduce genetic diversity, the period of growth between bottlenecks can have the reverse effect: 14 generating substantial de novo adaptive mutations and promoting their survival (Wahl et al. 2002) . 15 The survival of a novel adaptive lineage is predicted to depend not only to the timing and severity 16 of bottlenecks, but on the details of the microbial life history and the trait affected by the mutation 17 retical work, a model of a viral quasispecies undergoing periodic transmission events predicts that 24 pathogens should maintain a mutation-selection balance with high virulence if the pathogen is hori-25 zontally transferred, if the bottleneck size is not too small, and if the number of generations between 26 bottlenecks is large (Bergstrom et al. 1999) . shed new light on this issue. In addition, we note that many human viruses -including human 33 immunodeficiency virus, hepatitis B virus, and influenza A virus -reproduce by viral budding in 34 the context of a potentially limited target cell population (Garoff et al. 1998) ; the survival of 35 de novo mutations has not yet been predicted for this microbial life history. Thus, the effects of 36 transmission bottlenecks on the genetic diversity of viral pathogens, that is, on the fate of de novo 37 mutations, are as yet unknown.
38
In this contribution, we first develop a deterministic model of the within-host dynamics of early 39 infection by a viral pathogen. We couple this to a detailed life-history model, using a branching 40 process approach to follow the fate of specific de novo mutations that are either phenotypically 41 neutral, or affect various life-history traits. These techniques allow us to predict which adaptive 42 changes in virus life history are most likely to persist, and how the diversity of the viral sequence 43 is predicted to change between donor and recipient. We can thus predict, for example, the rate at 44 which de novo single nucleotide polymorphisms arise during the course of a single infection, and are 45 transmitted to a subsequent host.
46
Throughout the paper, we will illustrate our results with parameters that have been chosen to model 47 the life history and transmission dynamics of influenza A virus (IAV). IAV is an orthomyxovirus 48 (Bouvier and Palese 2008) that imposes a significant burden on global health, causing seasonal 49 epidemics, sporadic pandemics, morbidity and mortality (Carrat and Flahault 2007) . It is 50 estimated that infection with seasonal strains of influenza results in around 36,000 deaths per year 51 in the United States, although exact numbers are difficult to determine (Chowell et al. 2008) .
52
Mathematical modelling is a well-established tool for predicting the evolution of influenza (Larson 53 et al. available. Our approach allows direct access to this question.
67

LIFE HISTORY AND TRANSMISSION MODEL
68
Deterministic Model We use a system of ordinary differential equations (ODEs) to approximate 69 the within-host dynamics during the early stages of infection by a pathogenic virus, assuming a 70 life history that involves infection of a target cell, an eclipse phase, and finally an infectious stage. 71 Specifically, we propose: 72 target cells:
infected (eclipse):
budding cells:
free virus: the time-varying target cell population, and can be written A(t) = αy T (t), with the corresponding 81 mean attachment time, A(t) −1 .
82
A limitation of ODE approaches is that all transitions are described by exponential distributions. 83
To relax this assumption, we introduce a sequence of k infected stages through which infected cells 84 pass before reaching the budding stage. This 'chain of independent exponentials' allows for more 85 realistic gamma distributions of eclipse times (Wahl and Zhu 2015) . Specifically, we replace system 86
(1) with: 87 target cells:
eclipse stage 1:
free virus:
When k = 1, this model reduces to System 1; for k > 1, y 1 gives the population of initially infected 88 cells, which pass through k eclipse stages at rate kE before budding. The transition rate kE is 89 set such that the expected time in the eclipse phase, in total, is fixed at 1/E for any value of k. 90
In the supplementary material, we also investigate a model in which the death term, D, is set to 91 zero during the eclipse stages and only acts during the budding stage. This likewise gives a more 92 realistic distribution for the lifetime of infected cells.
93
The founding virus begins as an initial population of free virus (the initial infectious dose, v(0) = v 0 ) 94 at time t = 0. We do not assume that all viral particles in the founding dose are genetically identical, 95
but we do assume that they are phenotypically identical, that is, they are described by the same 96 parameter values in the deterministic model. As described further in the stochastic model below, we 97 assume that disease transmission occurs at time τ during the peak viral shedding period (when the 98 free virus population, v is at or near a peak value). For the transmission event to a new susceptible 99
individual, a new founding population is sampled from the total viral load. In particular, each free 100 viral particle becomes part of the infectious dose transmitted to the next individual with probability 101
F . The value of F is computed such that for the founding virus, the expected size of the transmitted 102 in an environment for which the overall dynamics of the target cell population are driven by the 118 deterministic system (2). Thus we treat the free virus, eclipse-phase cells and budding cells in the 119 mutant lineage stochastically, but use the deterministic system to predict the susceptible target cell 120 population at any time.
121
As in the deterministic model, free virions clear at a constant rate C or adsorb to susceptible host 122 cells at rate A(t). Note that the attachment rate of a free virion is not constant; it depends on 123 target cell availability, such that A(t) = αy T (t), where y T (t) is the target cell population predicted 124 by system (2). Host cells enter the eclipse phase when a virion adsorbs, and exit the eclipse phase 125
at rate E. After the eclipse phase, mature infected cells bud virions at rate B. Since budding itself 126
does not immediately kill the host cells (Garoff et al. 1998) , after infection the cell is subject to 127 a constant death rate D, or in other words the cell remains alive for an average time 1/D.
128
This stochastic growth process can be described as a branching process, using a multitype proba-129 bility generating function (pgf) to describe a single lineage of free virions (associated with dummy 130
variable (x 1 ), infected cells (x 2 ), and mature cells (x 3 ). As derived in the Appendix, the pgf for this 131 process, G(t, x 1 , x 2 , x 3 ), satisfies:
where A(t), B, C, D and E are attachment, budding, clearance, cell death and eclipse matura-133 tion rates, respectively. Equation (3) captures the time evolution of the pgf, given each of these 134 probabilistic events. As shown in the Appendix, Equation (3) can be converted to a system of 135
ODEs using the standard method of characteristics, and is thus amenable to numerical solution. 136
Analogous to System (2), Equation (3) can also be extended to include a chain of k infected stages 137 before the budding stage, yielding more realistic distributions of the eclipse time.
138
To estimate the probability that the lineage associated with a de novo mutation does not survive the 139 transmission bottleneck, we will need a pgf describing a complete cycle of in-host growth followed 140 by a transmission bottleneck. We thus numerically integrate the pgf G, described above, from time 141 0 to time τ , and then compose it with a pgf describing disease transmission. To describe disease 142 transmission, we simply assume that each free virion in the infected host is transmitted with fixed 143 probability F , as described above. As derived in the appendix, this approach allows us to estimate 144 the probability that a de novo mutation that first occurs at time t 0 is transmitted to the next host, 145
1 − X(t 0 ), the rate at which such "surviving" mutations arise at each time during the infection, 146 ν(t 0 ), and, ultimately, the probability that a given mutation occurs de novo and is transmitted to 147 the next host, P. To estimate the probability that a beneficial mutation ultimately survives, we substitute the pa-158 rameters above for the analogous parameters in the pgf G(t, x 1 , x 2 , x 3 ) and numerically evaluate 159 G(τ, x 1 , 1, 1), which describes the distribution of free virions in the mutant lineage at time τ , as 160
described in the Appendix. We then compose this function with the pgf describing disease transmis-161
sion. The accuracy of these numerical solutions was verified using an individual- for the founding population to double, the mutant lineage grows by a factor of 2(1 + s). Given the 168
founding growth rate g, we substitute the founding doubling t = ln ( The number of upper respiratory epithelial cells in a healthy adult is estimated to be 4 × 10 2010). The attachment rate α = 2.375×10 −9 per hour per cell provided in Table 1 yields a peak time 211
of τ = 54.5 hours, and implies a mean attachment time, 1/A(0), of just over one hour when target 212 cells are plentiful. We assume that disease transmission is most likely at the peak viral shedding 213 time, and thus study a transmission event that occurs at this peak time, τ . Note that when we 214 examine the sensitivity of the model, for example when changing v 0 , we leave the attachment rate 215 α fixed. We recompute the time course v(t) and assume that the transmission event occurs at the 216 peak value of v(t). The transmission time, τ , then differs slightly between cases. In no case was τ 217
outside the empirically estimated range of 48-72 hours.
218
The probability that each free virion survives the bottleneck and is transmitted to the next sus-219 ceptible individual is defined as F . This probability is calculated by using the peak number of 220 free virions, v(τ ), found by numerically solving model 2. As only free virions contribute to the 221 infectious dose, the fraction of free virions surviving the bottleneck is
is the founding population size for the next infected individual.
223
The mutation rate for influenza A, per nucleotide per replication, has been estimated as µ = 2×10 Free Virion Population Figure 2 shows what we will refer to as the mutation transmission rate, that is, the probability 239 that at least one copy of a specific mutation arises de novo during an infection time course, survives 240 genetic drift and is successfully transmitted to the subsequent host. Model predictions for beneficial 241 mutations affecting each life history trait are shown versus the selective coefficient, s; the intercept 242 at s = 0 shows the prediction for neutral mutations. Here we have assumed for comparison that 243 the baseline mutation rate is equal for all types of mutation, however the y-axis in Figure 2 scales 244 approximately linearly with µ. In the Supplementary Material, we illustrate results for a wide range 245 of mutation rates.
246
To interpret these results, the empirical mutation rate must be carefully considered. The rate 247 estimate we use reflects the probability, per replication, that a specific substitution occurs at a 248 specific nucleotide in the influenza A sequence, given that the substitution is non-lethal. Thus for 249 example if the substitution of interest is neutral or effectively neutral, the model predicts that this 250 substitution would occur de novo in the donor and be transmitted to a recipient about once in every 251 2000 transmission events. If the substitution of interest confers a selective advantage, the mutation 252 transmission rate would be higher. Clearly, a large fraction of viable mutations will be deleterious 253 and would be outcompeted before transmission; this would correspond to a lower overall mutation 254 rate as examined in the Supplementary Material and outlined further in the Discussion.
255
The most striking result of Figure 2 is the predicted evolvability of influenza A during a single 256 transmission cycle. The mutation transmission rate of one in two thousand, per substitution per 257 site, may contribute substantial diversity since the influenza A genome is a sequence of over 13,000 258 nucleotides with three possible substitutions per site. We will return to the interpretation and 259 implications of this prediction in the Discussion.
260
The near-overlapping lines in Figure 2 indicate that the mutation transmission rate does not vary 261 widely across life history traits, and also illustrates the maximum selective advantage made possible 262 by improvements to each trait. For example, clearance and cell death rates can only be reduced 263 to zero, limiting the range of s for these traits. Although there is no upper bound on the rates of 264 attachment or maturation to budding (eclipse rate), once these rates are effectively instantaneous, 265 further increases do not appreciably change the growth rate, and so higher s values are also inac-266 cessible for these traits. Similarly, increases to the budding rate cannot improve the growth rate 267 without bound, due to target cell limitation.
268
Results in Figure 2 assume the default parameter set (Table 1) Table 1. selective coefficient (s = 0.05) but vary the size of this transmission bottleneck. We find that the 271 mutation transmission rate increases roughly linearly with bottleneck size.
272
The results above compare mutations that have equivalent effects on the overall growth rate of the 273 virus, assuming that the underlying mutation rate is the same for all mutations. Although the 274 question of mutational accessibility is beyond our focus, some sense of the degree to which these 275 mutations might be physiologically achievable can be obtained by considering the relative changes 276
Size of Bottleneck 0 100 200 300 400 500 600 700 800 900 1000
Probability of Transmitting at Least One Mutant Table 1. required to the trait value. To this end, Figure 4 shows the relative change in each life history 277 parameter necessary to achieve a specific increase in growth rate (selective coefficient). To incur an 278 advantage of s = 0.08, for example, requires less than a 10% change in the rate at which cells leave 279 the eclipse phase and begin budding; in contrast the attachment rate would need to double (change 280
by over 100%) to achieve the same selective advantage. Note again that clearance and cell death 281 rates can only be reduced by at most 100%, limiting the range of their possible effects. For the 282 other three traits, as described previously, beneficial mutations can produce selection coefficients 283 in the approximate range 0 < s < 0.2, but further rate increases produce diminishing returns and 284 fitness saturates. Figure 4: The change in selective coefficient achieved by a given absolute percent change in trait value, for mutations affecting the five life-history traits. For example, large changes in attachment rate would be required to achieve the same advantage as relatively small changes in eclipse timing. Figure 2 gives the overall probability that a de novo mutation is generated and passed on. As 286 described in the Methods, this value reflects the integrated probability of occurrence and survival for 287
mutations that could first occur at any time during the infection time course. To better understand 288 the dynamics of this process, in Figure 5 we show the predicted survival probability, the probability 289 that the mutation survives and is transmitted to the next host, for mutations that arise at time Figure 5: Given that a de novo mutation first occurs at time t 0 after the start of the infection, the probability that at least one copy of it is transmitted to the next host, versus t 0 . All mutations have a selective advantage of s = 0.05, except for the curve marked "neutral", for which s = 0. Parameters as provided in Table 1 . The inset shows the same results with in a semilog plot. t 0 during the infection time course. Despite the fact that transmission to the next host occurs at 291 54.5 hours, the figure gives the impression that mutations that arise after about the first 10 hours 292 of infection have little chance of survival.
293
The results in Figure 5 are mitigated, however, by the fact that many more replication events occur 294 later during the growth phase. To investigate the rate at which surviving mutations (mutations that 295 are transfered to the next host) first occur, we consider the product of the transmission probability 296 for mutations that arise at each time and the number of new virions produced at that time, By B (t 0 ). these estimates scale directly with the underlying mutation rate and the size of the transmission 320 bottleneck. Despite this inherent uncertainty, our results predict that a small handful of mutations 321 occurring de novo in the donor will be transmitted to each recipient of IAV. unlikely that all transmitted lineages would be phenotypically identical. Thus a clear direction for 327 future work would be to expand our approach to track multiple distinct lineages within the host, 328
and predict the fates of mutations occurring on these backgrounds.
329
We can also take our estimate of (1.5 × 10 −3 non-lethal substitutions per site per transmission 330 event)×(10-50% neutral or beneficial) to predict 1.5 − 7. A, changes to the clearance rate of the free virus or death rate of infected cells could only achieve a 359 selective advantage of s < 0.1. This occurs mathematically because these rates cannot be reduced 360 below zero; it follows intuitively because even if infected cells or virus never die or lose infectivity, 361 growth remains limited by other processes. Mutations with larger beneficial effects, in the range 362 0.1 < s < 0.2, are accessible only by reducing the eclipse phase, or through very large magnitude 363 changes to the attachment or budding rates. Given that predicted differences in survival probability 364
for the different traits are rather modest ( Figure 5 ), these results suggest that small magnitude 365 changes in the eclipse timing of influenza A will be subject to selective pressure. The limits we 366 observe in the achievable growth rate suggest that larger effect beneficial mutations in influenza A 367
are not only unlikely, they may not be physically possible given the life history of this virus.
368
We have focused this study on the in-host life history of the virus. In principle, however, a beneficial 369 mutation could also affect the transmissibility of the lineage (parameter F ), producing virions that 370
are preferentially transferred to a new host (Handel and Bennett 2008) . This would be distinct 371 from mutations that increase viral load; mutations affecting F would increase the probability that 372
an individual viral particle is transmitted, for example by prolonging the stability of the virion in 373 the external environment.
374
These results explore mutations affecting a single trait in isolation. Clearly higher fitness could 375 be achieved by mutations that affect several traits, if beneficial pleiotropic mutations are available. 376 Previous work suggests that the survival probability of pleiotropic mutations typically falls between 377 the predictions obtained for single-trait mutations of equivalent selective effect (Wahl and we illustrate the case k = 1. Taking into account the stochastic events of attachment, budding, 573
clearance, cell death and cell maturation, is is straightforward to demonstrate that the probability 574 generation function (pgf) describing the time evolution of the lineage must satisfy:
Taking the limit as ∆t → 0, Equation 4 yields the following linear partial differential equation:
Equation 5 can be converted to a system of ordinary differential equations using the standard method of characteristics, which yields the following system of ordinary differential equations
This system can be solved numerically to determine the value of G at time τ , given the known initial 577 condition corresponding to a single free virion at time t 0 , G(t 0 , x 1 , x 2 , x 3 ) = x 1 . For convenience we 578 let G(t 0 , x 1 ) = G(τ, x 1 , 1, 1) under this initial condition.
579
The function G(t 0 , x 1 ), then, gives the distribution of free virions at time τ , just before disease 580 transmission, given the lineage began with a single virion at time t 0 . Composing this with the pgf 581 of the bottleneck process, we obtain G(t 0 , 1 − F + F x 1 ) as the pgf describing the distribution of 582 free virions transmitted to a new host (given that one new host is infected). The probability that 583 a given lineage, that arose at time t 0 , is not transmitted to the new host is obtained by evaluating 584 at x 1 = 0:
We then use this to compute the expected rate at which surviving mutant strains appear at time 586 t 0 , where "surviving" means the lineage will be transfered to the next host:
where µ is the probability that the mutation of interest occurs, per new virion produced. We use 588 this to compute S, the expected number of times that the mutation of interest occurs de novo, over 589 the course of the infection, and survives to be transmitted to the next host:
Consider dividing the time interval (0, τ ) such that δt = τ /N and t i = iδt. In this case for small 591 δt, the quantity ν(t 0 )δt approximates the probability that a surviving mutation occurs during time 592
interval (t 0 , t 0 + δt). This allows us to compute P, the probability that the mutation of interest 593 occurs de novo during the course of the infection and is transmitted to the new host:
which by product integration can be succinctly expressed as:
We also compute the expected number of mutant virions transmitted to the recipient host, N . We 596 do this by first computing ∂ x G(t 0 , x)| x=1 , which gives the expected number of mutant virions at 597 time τ , given that a mutant virion was produced at time t 0 . We multiply this value by the number 598 of mutant virions being produced at time t 0 , µBy B (t 0 ), and integrate from 0 to τ , to get the total 599 expected number of mutant virions at time τ . Multiplying by the bottleneck fraction, F , gives the 600 expected number of mutant virions transmitted to the recipient host:
Note that S and N differ because each de novo mutation produces a lineage that could in principle 602 contribute more than one virion to the recipient. Figure S1: The number of times that a given mutation is expected to arise de novo, during a single infection time course, and produce a lineage that is transmitted to the next infected individual (S, as described in the Appendix), versus the selective coefficient. This quantity scales linearly with µ, the mutation rate. Free Virion Population Figure S3 : The time course of influenza A infection over the span of a week (168 hours). This figure is analogous to Figure 1 , except that the cell death rate, D, has been set to zero during the eclipse stages, and increased during the budding phase such that the mean infected cell lifetime is unchanged. Other parameters as provided in Table 1 . The infection time course is relatively insensitive to these changes in the distribution of infected cell lifetimes. Figure S4 : The probability that at least one de novo mutation arises during the infection time course and is passed to the next host, P, versus the selective coefficient, s. This figure is analogous to Figure 2 , except that the cell death rate, D, has been set to zero during the eclipse stages, and increased during the budding phase to yield the same mean infected cell lifetime. Other parameters as provided in Table 1 . We find that the transmission of de novo mutations is insensitive to these changes in the distribution of infected cell lifetimes. Free Virion Population Figure S5 : The time course of influenza A infection over the span of a week (168 hours). This figure is analogous to Figure 1 , except that the initial target cell population, y T (0), has been reduced by a factor of 3. Although complete desquamation is the expected outcome of the infection, it is possible that spatial considerations might spare a fraction of the epithelial cells in the upper respiratory tract; we therefore included this case in sensitivity analysis. Other parameters as provided in Table  1 . Comparing with Figure 1 , the magnitude of the infection is scaled and the dynamics are slightly delayed. However this has little impact on the probability of transmission of a mutation (see Figure  S6 ). Figure S6 : The probability that at least one de novo mutation arises during the infection time course and is passed to the next host, P, versus the selective coefficient, s. This figure is analogous to Figure 2 , except that the initial target cell population, y T (0), has been reduced by a factor of 3.
Other parameters are as provided in Table 1 . We find that the transmission of de novo mutations is insensitive to the initial number of available target cells. Figure S7: The effect of mutation rate on the probability of transmission. The probability that at least one copy of a de novo mutation is transmitted to the next host is plotted against the selective coefficient, for a mutation that increases the viral attachment rate. The mutation rate per replication event, µ, is varied. Other parameters as provided in Table 1 .
